Gynecomastia in Patients with Prostate Cancer: A Systematic Review
Conclusions Bicalutamide-induced gynecomastia and/or mastodynia can effectively be managed by oral tamoxifen (10–20 mg daily) or radiotherapy without relevant side effects. Prophylaxis or therapeutic treatment with tamoxifen results to be more effective than radiotherapy.
Source: PLoS One - Category: Biomedical Science Authors: Anders Fagerlund et al. Source Type: research
More News: Arimidex | Biomedical Science | Cancer | Cancer & Oncology | Databases & Libraries | Gynecomastia | Oral Cancer | Prostate Cancer | Study | Tamoxifen